论文部分内容阅读
目的:探析孟鲁司特钠治疗小儿哮喘的临床效果。方法:选取2013年9月至2015年9月该院收治的126例小儿哮喘患儿为研究资料,按入院时间将其分为两组各63例。对照组采用常规治疗,观察组采用孟鲁司特钠治疗,对比分析临床治疗效果。结果:观察组的临床治疗有效率为96.83%,优于对照组的(82.54%,P<0.05);治疗后,观察组的肺功能及哮喘症状改善情况优于对照组(P<0.05)。结论:孟鲁司特钠治疗小儿哮喘的临床效果较为显著,可改善患儿的哮喘症状和肺功能,且副作用小、复发率低,值得在临床上进一步推广和应用。
Objective: To investigate the clinical efficacy of montelukast sodium in the treatment of pediatric asthma. Methods: A total of 126 pediatric asthmatic children admitted to our hospital from September 2013 to September 2015 were selected as study materials, and divided into two groups according to the time of admission. The control group was treated by conventional therapy. The observation group was treated with montelukast sodium, and the effect of clinical treatment was compared. Results: The effective rate of clinical treatment in observation group was 96.83%, which was better than that in control group (82.54%, P <0.05). After treatment, the improvement of lung function and asthma symptom in observation group was better than that in control group (P <0.05). Conclusion: Montelukast sodium treatment of pediatric asthma clinical effect is more significant, can improve children with asthma symptoms and pulmonary function, and side effects, low recurrence rate, it is worth further clinical application.